Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours) + Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours) + Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours) + Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)
Phase 1Recruiting 0 watching 0 views this week💤 Quiet
28
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Conditions
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Trial Timeline
Oct 30, 2026 → May 20, 2028
NCT ID
NCT06801223About Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours) + Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours) + Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours) + Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours) + Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours) + Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours) + Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours) is a phase 1 stage product being developed by Innoviva for Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC). The current trial status is recruiting. This product is registered under clinical trial identifier NCT06801223. Target conditions include Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC).
Hype Score Breakdown
Clinical
10
Activity
5
Company
5
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06801223 | Phase 1 | Recruiting |
Other Products from Innoviva
Angiotensin-IIApproved
80
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours) + Ceftriaxone for Injection + Amoxicillin + Azithromcyin + clarithromycin + Clofazimine + Ethambutol + Amikacin Injection + tigecycline + Imipenem + Cilastatin + Cefoxitin + Amikacin (Inhalation) + linezolid + Trimethoprim / Sulfamethoxazole + Doxycycline + moxifloxacin + bedaquiline + RifabutinPhase 2
47
Eravacycline 2mg/kg + Eravacycline 1.5mg/kgPhase 2
47